Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes

por Hu, Jing-Yi, Zou, Hai-Lan, Li, Yan-Hua, Nie, Dong-Ying, Chao, Chen, Liu, Jin-Han, Ding, Jin, Zhou, Zhi-Guang, Xiao, Yang
Publicado 2021